Summit Therapeutics
SMMT
£20.55
Share price
-4.26%
Change (1 day)
145.17%
Change (1 year)
Categories
Market capitalization of Summit Therapeutics (SMMT)
Market cap: £15.26 Billion
As of July 2025 Summit Therapeutics has a market cap of £15.26 Billion. This makes Summit Therapeutics the world's 1047th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Summit Therapeutics from 2015 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | £15.26 B | 42.63% |
| 2024 | £10.70 B | 645.31% |
| 2023 | £1.43 B | 103.01% |
| 2022 | £0.70 B | 263.19% |
| 2021 | £0.19 B | -31.35% |
| 2020 | £0.28 B | 246.04% |
| 2019 | £81.96 M | 449.9% |
| 2018 | £14.9 M | -87.82% |
| 2017 | £0.12 B | 43.44% |
| 2016 | £85.3 M | -10.32% |
| 2015 | £95.12 M |
End of Day market cap according to different sources
On Jul 28th, 2025 the market cap of Summit Therapeutics was reported to be:
£15.26 Billion
£15.26 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | £1.01 B | -93.32% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | £4.61 B | -69.76% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | £0.16 B | -98.90% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | £92.87 M | -99.39% | 🇺🇸 USA |